Today: 12 April 2026

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Intel stock jumps 8% on CES 2026 18A chip debut as INTC investors eye the next catalyst

Intel stock jumps 8% on CES 2026 18A chip debut as INTC investors eye the next catalyst

Intel shares rose 8.3% to $43.37 Wednesday after unveiling laptop chips built on its new 18A process at CES in Las Vegas. The company said preorders for laptops using the chips start Jan. 6, with shipments beginning Jan. 27. Melius Research upgraded Intel to “buy” and set a $50 target. Intel outperformed rivals as the iShares Semiconductor ETF fell 1.2% and AMD dropped 2.3%.
7 January 2026
Exxon Mobil stock slides as Trump’s Venezuela oil plan drags crude, filing due after close

Exxon Mobil stock slides as Trump’s Venezuela oil plan drags crude, filing due after close

Exxon Mobil shares fell 1.1% to $119.71 Wednesday as oil prices dropped after President Trump said Venezuela would send up to 50 million barrels of sanctioned oil to the U.S. Brent crude slipped 0.7% to near $60 a barrel. Exxon is set to release a fourth-quarter “earnings considerations” 8-K after market close. Trump plans to meet oil executives later this week to discuss Venezuela.
Eli Lilly stock climbs on Ventyx buyout talk as dealmaking takes center stage

Eli Lilly stock climbs on Ventyx buyout talk as dealmaking takes center stage

Eli Lilly shares rose 3.3% to $1,099.44 after reports it is in advanced talks to buy Ventyx Biosciences for over $1 billion, according to the Wall Street Journal. The news follows Lilly’s new obesity-drug partnership with Nimbus and comes as Novo Nordisk launches an oral Wegovy pill in the U.S. Investors await updates at next week’s J.P. Morgan healthcare conference and Lilly’s upcoming earnings call.
7 January 2026
UnitedHealth stock falls despite new price targets as Wall Street eyes Jan. 27 earnings

UnitedHealth stock falls despite new price targets as Wall Street eyes Jan. 27 earnings

UnitedHealth shares fell over 2% to $340.44 Wednesday morning, erasing part of Tuesday’s gain. The drop followed analyst moves, with Bernstein raising its target to $444 and Evercore ISI starting coverage at $400. Investors await UnitedHealth’s Jan. 27 results and Medicare Advantage rate updates. Humana and Cigna also declined.
Google (Alphabet) GOOG stock rises as House tees up self-driving hearing; Waymo in focus

Google (Alphabet) GOOG stock rises as House tees up self-driving hearing; Waymo in focus

Alphabet Class C shares climbed 1.7% to $319.98 in morning trading Wednesday, outperforming a mixed U.S. market. A U.S. House subcommittee set a Jan. 13 hearing on draft bills to ease deployment of driverless vehicles, including raising the exemption cap to 90,000 per year. CES in Las Vegas drew attention to autonomous tech and AI, with Waymo and Nvidia in focus.
Palantir stock ticks higher as Truist starts coverage with $223 target, valuation stays in play

Palantir stock ticks higher as Truist starts coverage with $223 target, valuation stays in play

Palantir Technologies shares rose 0.9% to $181.38 Wednesday after Truist initiated coverage with a “buy” rating and a $223 target, citing strong AI-driven revenue growth. The stock traded at over 400 times earnings, raising concerns about high expectations. Investors remained cautious ahead of Friday’s U.S. jobs report, which could impact tech valuations. Palantir’s next earnings are expected Feb. 2.
7 January 2026
Netflix stock dips after Warner rejects Paramount bid, with earnings two weeks away

Netflix stock dips after Warner rejects Paramount bid, with earnings two weeks away

Netflix fell 0.3% to $90.42 after Warner Bros Discovery urged shareholders to reject Paramount Skydance’s $30-per-share bid and back Netflix’s $27.75-a-share agreement. CFRA downgraded Netflix to “Hold,” citing risks from the Warner deal, which could raise debt and face lengthy regulatory review. Warner shares rose 0.2%, Paramount Skydance dropped 0.5%. Netflix reports earnings Jan. 20.
Meta Platforms stock drops as China reviews Manus AI deal, legal risks resurface

Meta Platforms stock drops as China reviews Manus AI deal, legal risks resurface

Meta shares fell 2.2% to $646.20 Wednesday after reports that Chinese officials are reviewing its $2 billion acquisition of AI startup Manus, raising the risk of regulatory delays. A U.S. appeals court also appeared skeptical of Meta’s bid to dismiss lawsuits over alleged harm to children. C.J. Mahoney was named chief legal officer, succeeding Jennifer Newstead, who will join Apple in March.
7 January 2026
Sandisk stock dips today after Nvidia CES boost; BofA lifts SNDK target to $390

Sandisk stock dips today after Nvidia CES boost; BofA lifts SNDK target to $390

Sandisk shares fell 2.9% to $339.4 Wednesday morning after surging 27% Tuesday on AI-storage enthusiasm sparked by Nvidia’s CES remarks. Bank of America raised its price target to $390, citing strong NAND demand and rising prices. Western Digital dropped 10.2% and Seagate slid 8.9%. Investors await Sandisk’s Jan. 29 earnings for pricing and capacity updates.
Nvidia stock climbs on China H200 demand comments as Feb. 25 earnings loom

Nvidia stock climbs on China H200 demand comments as Feb. 25 earnings loom

Nvidia shares rose 1.8% to $190.55 after CEO Jensen Huang said Chinese purchase orders, not announcements, would signal approval for H200 chip imports. Data-center cooling stocks fell following Nvidia’s comments on lower cooling needs. Traders are watching U.S. export-license timing ahead of Nvidia’s Feb. 25 results. Rival AMD dropped 1.9% after unveiling new AI chips at CES.
1 405 406 407 408 409 736

Stock Market Today

  • Anti Puffiness Eye Products Market Set for Strong Growth Through 2035 on Ingredient Innovation
    April 12, 2026, 9:55 AM EDT. The global Anti Puffiness Eye Products market is poised for accelerated growth from 2026 to 2035, driven by advanced ingredient breakthroughs and evolving consumer skincare demands. According to IndexBox, the sector will outpace broader facial skincare, spurred by the rise of sophisticated routines and digital ingredient education. Growth varies by region-mature markets focus on premium, science-backed products, while emerging markets expand through new consumers. Increased competition will hinge on supply chain control for specialized ingredients such as peptides and caffeine derivatives, as well as clinical proof of product claims. Brands face pressure from private-labels in mass segments, pushing toward premium and 'masstige' tiers. Innovation in delivery methods and packaging plays a key role, alongside rising regulatory scrutiny that favors companies with strong R&D. Profitability will cluster around players mastering premiumization and direct-to-consumer engagement.

Latest article

Bitcoin Price Today Slips After Iran Talks End Without Deal, but ETF Buyers Keep Showing Up

Bitcoin Price Today Slips After Iran Talks End Without Deal, but ETF Buyers Keep Showing Up

12 April 2026
Bitcoin fell 1.4% to $71,707 on Sunday after U.S.-Iran talks in Islamabad ended without a deal. Spot bitcoin ETFs logged net inflows last week, with BlackRock and Fidelity leading Friday’s buying. Morgan Stanley launched its MSBT fund on April 8, the first Wall Street bank to debut a bitcoin ETF. U.S. inflation data showed headline CPI up 3.3% in March, while core CPI rose 2.6%.
XRP Price Today: XRP Slips to $1.33 After Failed U.S.-Iran Talks Hit Crypto

XRP Price Today: XRP Slips to $1.33 After Failed U.S.-Iran Talks Hit Crypto

12 April 2026
XRP slipped about 1% to $1.33 on Sunday after U.S.-Iran peace talks in Islamabad ended without a deal, pressuring crypto markets. The token traded in a narrow range, with bitcoin and ether also weaker. XRP’s market cap stands at $81.7 billion, with $1.96 billion in daily volume. The token remains 63.5% below its all-time high.
Gold Price Today: Bullion Near $4,762 After Weekly Gain, but Failed Iran Talks Cloud Outlook

Gold Price Today: Bullion Near $4,762 After Weekly Gain, but Failed Iran Talks Cloud Outlook

12 April 2026
Spot gold steadied at $4,761.79 an ounce Friday after a third weekly gain, with U.S. futures at $4,787.40. The dollar posted its biggest weekly drop since January, making gold cheaper for non-U.S. buyers. U.S.-Iran talks ended without a deal, keeping geopolitical risks high. China’s central bank increased gold reserves for a 17th month, reaching 74.38 million ounces.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 12.04.2026

12 April 2026
Futu Holdings (FUTU) rose 10.2% in the past week but trades 13.4% below its January level. Shares closed at $154.50, while analysts estimate intrinsic value at $245.48. The company posted a 92.2% return over 12 months. Valuation models indicate earnings exceed risk costs, supporting long-term growth projections.
India F-35 Deal Hits Pause: Lockheed Martin Says No Direct Talks, U.S. Door Still Open

India F-35 Deal Hits Pause: Lockheed Martin Says No Direct Talks, U.S. Door Still Open

11 April 2026
Lockheed Martin said it is not in direct talks with India over the F-35, clarifying that any approach must go through official U.S. and Indian channels under the Foreign Military Sales process. Indian officials confirmed no formal discussions on acquiring the F-35 have begun. India recently approved a $40 billion military upgrade, including other fighter jets, while Lockheed’s F-21 remains in a separate competition.
Go toTop